These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7977162)

  • 21. Phase I/II trial of nonpegylated liposomal doxorubicin, cyclophosphamide, vincristine, and prednisone in the treatment of newly diagnosed aggressive non-Hodgkin's lymphoma.
    Tulpule A; Espina BM; Berman N; Buchanan LH; Smith DL; Sherrod A; Dharmapala D; Gee C; Boswell WD; Nathwani BN; Welles L; Levine AM
    Clin Lymphoma Myeloma; 2006 Jul; 7(1):59-64. PubMed ID: 16879771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multicenter phase II study of the CyclOBEAP (CHOP-like + etoposide and bleomycin) regimen for patients with poor-prognosis aggressive lymphoma.
    Niitsu N; Okamoto M; Aoki S; Okumura H; Yoshino T; Miura I; Hirano M
    Ann Hematol; 2006 Jun; 85(6):374-80. PubMed ID: 16518603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autologous peripheral blood stem cell transplantation to treat CHOP-refractory aggressive subcutaneous panniculitis-like T cell lymphoma.
    Nakahashi H; Tsukamoto N; Yamane A; Saitoh T; Uchiumi H; Handa H; Karasawa M; Murakami H; Kojima M; Nojima Y
    Acta Haematol; 2009; 121(4):239-42. PubMed ID: 19556752
    [No Abstract]   [Full Text] [Related]  

  • 25. Phase III trial of cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) versus cisplatin, etoposide, bleomycin and prednisone (CisEBP) for the treatment of advanced non-Hodgkin's lymphoma of high grade malignancy. The Danish Lymphoma Study Group.
    Andersen J; Thorling K; Bentzen SM; Brincker H; Christensen BE; Pedersen M
    Acta Oncol; 1990; 29(8):995-9. PubMed ID: 1703769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Alternating chemotherapy with cyclophosphamide, adriamycin, vincristine and prednisolone (CHOP); etoposide, procarbazine, vindesine and prednisolone (EPVP) as a treatment for advanced-stage Hodgkin's disease].
    Kumagai K; Takagi T; Sakai C; Wakatsuki S
    Gan To Kagaku Ryoho; 1996 Mar; 23(4):499-501. PubMed ID: 8678506
    [No Abstract]   [Full Text] [Related]  

  • 27. Predicting therapeutic outcome in patients with diffuse histiocytic lymphoma treated with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP).
    Armitage JO; Dick FR; Corder MP; Garneau SC; Platz CE; Slymen DJ
    Cancer; 1982 Nov; 50(9):1695-702. PubMed ID: 6749279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination chemotherapy of diffuse histiocytic lymphoma with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP).
    Elias L; Portlock CS; Rosenberg SA
    Cancer; 1978 Oct; 42(4):1705-10. PubMed ID: 361209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful treatment of refractory subcutaneous panniculitis-like T-cell lymphoma with allogeneic peripheral blood stem cell transplantation from HLA-mismatched sibling donor.
    Ichii M; Hatanaka K; Imakita M; Ueda Y; Kishino B; Tamaki T
    Leuk Lymphoma; 2006 Oct; 47(10):2250-2. PubMed ID: 17071503
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group Study.
    Goodman GE; Crowley JJ; Blasko JC; Livingston RB; Beck TM; Demattia MD; Bukowski RM
    J Clin Oncol; 1990 Jan; 8(1):39-47. PubMed ID: 2153194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Aggressive chemotherapy in generalized eosinophilic granuloma in adults].
    Görg C; Görg K; Gropp C; Havemann K
    Onkologie; 1984 Dec; 7(6):360-2. PubMed ID: 6396563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotropic B-cell lymphoma with telangiectasia, accompanied by panniculitic formation.
    Nishiyama H; Tanei R; Motegi T; Ohta M; Sawabe M
    J Dermatol; 2004 Dec; 31(12):1032-5. PubMed ID: 15801271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subcutaneous panniculitis-like T-cell lymphoma in a patient with long-term remission with standard chemotherapy.
    Zhang H; Gupta R; Wang JC; Lipton JF; Huang YW
    J Natl Med Assoc; 2007 Oct; 99(10):1190-2. PubMed ID: 17987923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The combined modality therapy of diffuse histology non-Hodgkin's lymphoma with cyclophosphamide, adriamycin, vincristine, prednisone (CHOP) and total body irradiation.
    Weick JK; Antunez A; Kraus TA; Fabian CJ; Dixon D
    Int J Radiat Oncol Biol Phys; 1983 Aug; 9(8):1205-7. PubMed ID: 6347997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma.
    Fisher RI; Gaynor ER; Dahlberg S; Oken MM; Grogan TM; Mize EM; Glick JH; Coltman CA; Miller TP
    N Engl J Med; 1993 Apr; 328(14):1002-6. PubMed ID: 7680764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chidamide induces long-term remission in rare subcutaneous panniculitis-like T-cell lymphoma: An unusual case report and literature review.
    Li L; Wu C; Chai Y; Dong C; Zhao L
    Int J Immunopathol Pharmacol; 2021; 35():20587384211009342. PubMed ID: 33845613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nasal-type natural killer cell lymphoma preceded by benign panniculitis arising in an asymptomatic HTLV-1 carrier.
    Kunisada M; Adachi A; Matsumoto S; Ogawa Y; Horikawa T; Iwatsuki K
    Int J Dermatol; 2003 Sep; 42(9):710-4. PubMed ID: 12956685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytophagic histiocytic panniculitis with atypical lymphocytes in peripheral blood.
    Makino S; Kamura J
    Intern Med; 1992 Nov; 31(11):1317-21. PubMed ID: 1295632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
    Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
    Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subcutaneous T-cell lymphoma: report of two cases.
    Wasik F; Kołodziej T; Jeleń M; Pejcz J
    J Eur Acad Dermatol Venereol; 1998 Jan; 10(1):62-6. PubMed ID: 9552760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.